Viral Infection in Asthma (VIA) Trial
Phase 4
60
about 4.7 years
18–40
1 site in VA
What this study is about
Researchers are testing if a treatment called dupilumab helps prevent asthma symptoms after being exposed to the common cold virus. Dupilumab is an injectable drug that blocks inflammation in the lungs. The trial will involve adults and track asthma symptoms using lung function tests, questionnaires, and other methods.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Dupilumab Injectable Product
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
injection
Secondary: Change in symptoms post-rhinovirus inoculation
Respiratory